BioWorld

Feb. 14, 2002

Genetastix’s Yeast-Based Platform Draws Antibody Deal With Hyseq

Gemin X, Tranzyme Collaborate To Fight Neurological Disorders

Other News To Note

Array Raises $30M Publicly Through Sale Of 3M Shares

Pharmacopeia, Organon Agree To New Five-Year Collaboration

Pharmacopeia Inc. entered a new, five-year agreement with N.V. Organon, the pharmaceutical unit of the Netherlands’ Akzo Nobel, thus extending a business relationship that had its beginnings in the mid-1990s. (BioWorld Today) Read More

NIH changes set industry up for workforce, ideas drought

BioWorld

On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...

Today's news in brief

BioWorld

BioWorld briefs for March 6, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for March 6, 2025

Roche looks to grow with sequencing by expansion tech

BioWorld MedTech

Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...

Illustration of Magnet Biomedicine's Trueglue platform

Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology

BioWorld

About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...